.png)
Lighthouse
The Importance and Underuse of Germline Testing
Germline testing for inherited genetic variants is recommended to many people with cancer, yet such useful testing is notably underutilized.
top of page
Lighthouse
MSLs: The Value of Local Knowledge
Medical Science Liaisons are vital to foster relationships with HCPs, educating them about new treatments, and implementing clinical trials.
Lighthouse
Single-Gene Testing vs. NGS: Seeking One Target or Many
Choosing NGS first rather than Single-Gene Testing in cancer is a financially effective and diagnostically efficient strategy in many cases.
Lighthouse
Raising Awareness of New Targeted Oncology Clinical Trials
To enroll in clinical trials for targeted cancer therapies, people must be aware of them; thus, raising awareness is vital to enrollment.
Lighthouse
Blood-based Biomarkers in Cancer
Liquid biopsy for cancer is non-invasive and easily repeated, permitting molecular profiling and many other purposes with strong accuracy.
Lighthouse
How Does Awareness of Biomarkers Compare to Prevalence?
We compared awareness in oncologists of selected biomarkers to the prevalence of actionable oncogenic mutations across cancers.
Lighthouse
RAS Biomarker Trending and Awareness in Oncologists
We examined RAS/KRAS trending and awareness for oncologists; results track strongly with the history of scientific KRAS advancements.
Lighthouse
NTRK Trending and Awareness in Community Oncologists
We analyzed trending and awareness patterns of NTRK and NTRK-targeting compounds in academic and community oncologists.
Lighthouse
The Value of Molecularly Defined Patient Advocacy Groups
Patient advocacy groups provide support, education, advocacy, and information sharing while including the patient perspective in healthcare.
Lighthouse
Does Every Cancer Patient Get Next Generation Sequencing?
NGS is useful for diagnosis and prognosis but also for treatment decisions and resistance monitoring yet it is not consistently used.
bottom of page